Cardiac hypertrophy is an important risk factor for cardiac morbidity and mortality. To unravel the underlying pathogenic genetic pathways, we hybridized left ventricular RNA from Transverse Aortic Constriction mice at 48 h, 1 week, and 2, 3, and 8 weeks after surgery to microarrays containing a 15K fetal cDNA collection. Key processes involved an early restriction in the expression of metabolic genes, accompanied by increased expression of genes related to growth and reactivation of fetal genes. Most of these genes returned to basal expression levels during the later, compensated hypertrophic phase. Our findings suggest that compensated hypertrophy in these mice is established by rapid adaptation of the heart at the cost of gene expression associated with metabolic activity, with only temporary expression of possible maladaptive processes. Therefore, the transient early changes may reflect a beneficial response to pressure overload, as deterioration of cardiac hemodynamic function or heart failure does not occur.
The heart is able to adapt to increased workload, injury, or defects in contractile performance by increasing muscle mass. Activation of intracellular signaling cascades results in cardiac hypertrophy, which can be defined as an increase in heart size resulting from the enlargement of existing cardiomyocytes [1] . Whereas compensatory cardiac remodeling seems beneficial at first, myocardial hypertrophy is recognized as an important risk factor for cardiac morbidity and mortality [2] . Much research has focused on the identification of molecular pathways and processes underlying cardiac hypertrophy [3] . A reactivation of fetal genes, such as natriuretic peptides (Nppa, natriuretic peptide precursor type A or ANF, atrial natriuretic factor), Myh7 (myosin, heavy polypeptide 7, cardiac muscle, β or Myhc-b, β myosin heavy chain) and α-skeletal actin [4, 5] , has been observed. In addition, intracellular Ca 2+ handling, apoptosis, extracellular matrix deposition, and fibrosis also play an important role [3, 6, 7] . Furthermore, many experimental and clinical studies in the hypertrophied and failing heart have reported changes in energy metabolism [8] [9] [10] . Although a substantial number of processes have been recognized to play an important role in the sequel of events resulting in cardiac hypertrophy, it is largely unknown how the expression of genes involved in this process is phased in time and how the expression profiles are mutually related.
To elucidate the alterations in cardiac gene expression during the various phases of myocardial hypertrophy and to assess the nature of the processes involved, we used global gene expression profiling at different time points to monitor thousands of different genes simultaneously. As a model for cardiac hypertrophy, we used a Transverse Aortic Constriction (TAC) mouse model, in which cardiac hypertrophy is induced by pressure overload. Gene expression profiles were determined in the left ventricles of TAC and sham-operated mice at 48 h, 1 week, and 2, 3, and 8 weeks after aortic banding. Differentially expressed genes were further analyzed using Gene MicroArray Pathway Profiler (GenMapp) [11] , MAPPFinder [12] , TXTGate [13] , and Adaptive Quality-Based Clustering (AQBC) [14] to identify the nature of the processes up-or downregulated during the development of cardiac hypertrophy induced by pressure overload.
Results

Left ventricular hypertrophy in TAC mice
Either a TAC or a sham procedure was performed on 60 mice to be able to sacrifice 5 TAC and 5 sham-operated mice at 48 h, 1 week, and 2, 3, 8, and 28 weeks after surgery. Mortality rates due to the surgical procedure were 8% for TAC and 16% for sham-operated mice. The majority of the samples showed a 2:1 ratio of 28S to 18S ribosomal RNA and an A 260 :A 280 ratio of ∼2.0. This indicates good RNA quality. For four samples (one TAC and two shams at 1 week and one sham at 3 weeks) the yield and quality were insufficient and these were excluded. We balanced the number of TAC and sham mice for each time point. Unfortunately, at the 1-week time point, for technical reasons, only 2 sham-operated mice were available, while for all others at least 3 were. TAC mice at 1 week and 2, 3, and 8 weeks showed a reproducible degree of hypertrophy compared to sham mice: mean left ventricular mass (LVM)/ tibia length (TL) ratios increased by respectively 40, 33, 28, and 34% (Table 1) . TAC mice at 48 h did not show any increase [15] . The hypertrophy model was validated by realtime PCR for three genes known to be differentially expressed during hypertrophy ( Fig. 1 ). Nppa was upregulated with the highest fold change at 1 week (13.0-fold). Pln (phospholamban) was downregulated, with its peak value also at 1 week (5.1-fold). Both genes were differentially expressed at all time points, although fold changes decreased toward the later hypertrophic phase. Myh7 showed a slight upregulation at all time points. Our results showed that in this respect the hypertrophic response of the TAC mice is comparable with earlier reports on this model [15, 16] . Echocardiographic measurements in mice at 28 weeks after TAC showed no decrease in fractional shortening and no signs of heart failure. In addition, lung weight was not increased in these mice. Therefore, the conclusion can be drawn that the TAC procedure in the Swiss mice resulted in compensated cardiac hypertrophy due to pressure overload without deterioration of cardiac hemodynamic function during the experimental period of 8 weeks.
Quality of the microarray data
The positive controls (housekeeping genes) that were spotted in several concentrations showed consistent intensities throughout the slide. The negative controls (bacterial genes) were negative. Next, we compared different probes on the array representing the same gene (about 25% of the total number of analyzed probes with a known LocusLink Identifier (LL ID). When taking all time points together, about 90% of the total number (1865) of genes represented by more than one probe showed similar expression values, i.e., the fold change direction remains the same within a small range. In addition, replicate hybridizations were performed for five samples and these results showed that between-slide variability (when possible adjusting for labeling efficiency and spikes in the model) was close to zero. We feel that these are criteria that prove high-quality data and overall reproducibility.
As data from single genes are usually not sufficient to draw a conclusion about a specific process, we also tested the consistency with other genes involved in that process. This will provide evidence for the role of the entire process in the pathology observed. For part of the identified processes, a total of seven genes were confirmed by realtime PCR for all time points. Up-or downregulation of Psen1 at 48 h (presenilin 1) could not be confirmed by real-time PCR and upregulation of Tgfb1 (transforming growth factor β1) at 8 weeks did not reach the level of significance when measured by real-time PCR (Supplementary Table S1 ).
Number of differentially expressed genes in TAC mice
The total number of probes analyzed at 48 h, 1 week, and 2, 3, and 8 weeks was respectively 3066, 549, 4308, 6749, and 6881 (Fig. 2) . The low number at 1 week was due to the facts that only two shams were available for this time point and that the signal intensity of one of the slides was low. This became apparent after the whole experiment and analysis had been carried out. Although the remaining data at 1 week are fewer in number, they are as reliable as the data from the other time points (see the description of the data analysis in the supplementary data) and represent important processes. Therefore we have included them in our detailed analysis of the altered processes. The number of differentially expressed transcripts was largest at 48 h (454): 10.4% up-(215) and 13.8% downregulated (239). Most genes showed a more than 2-fold difference in expression and many genes more than 5-to 10-fold. At 1 week, 17.9% were upregulated (65), whereas 1.1% were downregulated (2) . At 2 and 3 weeks, most genes were downregulated: 0.6% up (18) vs 5.5% down (162) and 0.8% up (35) vs. 2.7% down (130), respectively. At 8 weeks, both up-and downregulated transcripts encompassed 2.8% of the analyzed transcripts (144 up and 147 down). The majority of genes at 1 week and 2, 3, and 8 weeks showed a less than 2-fold difference in expression. About 71% of the total number of transcripts analyzed had a known LL ID (Fig. 2 ).
Significant processes in cardiac hypertrophy
The most important processes identified for all time points, combining all tools, are shown in Table 2 and Fig.  3 . Results for each analysis tool separately are shown in Supplementary Table S2 (GenMAPP/MAPPFinder), S3 (TXTGate), and S5 (AQBC). Several previously reported genes and processes involved in cardiac hypertrophy were identified, e.g., Atp2a2 (sarcoplasmic reticulum Ca 2+ -ATPase), Mapkapk2 (MAP kinase-activated protein kinase 2), and MAPK and G-protein signaling. At 48 h, a variety of processes were identified, such as translation, signaling, response to heat and oxidative stress, proteolysis and peptidolysis, fatty acid (FA) metabolism, and energy conversion pathways as well as cytoskeletal, mitochondrial, and ribosomal processes. Downregulation of metabolic genes included genes involved in FA metabolism, the tricarboxylic (TCA) cycle, and mitochondrial oxidative phosphorylation (OXPHOS). At 1 week, genes involved in energy metabolism were slightly upregulated, but returned to normal levels at later stages ( Supplementary Table S4 ). A number of mitochondrial ribosomal genes and translation initiation factors were up-as well as downregulated at 48 h and 1 week. Cytoskeletal and sarcomeric genes were partly down-and partly upregulated at 48 h, whereas all of these genes analyzed at 1 week were upregulated. At 2, 3, and 8 weeks after banding, genes had returned to basal expression levels again ( Supplementary Table S4 ). With TXTGate, we identified additionally the downregulation of genes related to β-amyloid and the upregulation of genes encoding proteins with kinase activity at 48 h and genes involved in cancer/growth at 1 week after banding ( Supplementary Table S3 ). At 8 weeks, one cluster consisted of genes present in the HUGE (Human Unidentified Gene-Encoded) database and one of genes encoding binding proteins.
The most prominent changes in processes as a reaction to TAC occurred early and faded out at 2, 3, and 8 weeks ( Supplementary Table S4 ). Most of the later processes were less drastic as far as alterations in gene activity are concerned. Genes involved in TGFβ signaling seemed to be particularly involved at 8 weeks and were mainly upregulated. At 48 h, ubiquitin-activating and ubiquitin-conjugating enzymes, ubiquitin proteases, and ubiquitin ligases were up-and downregulated, while at the later time points these genes were mainly downregulated ( Supplementary Table S5 ). AQBC analysis ( Supplementary Table S5 ) did not provide additional information as most changes were specific for a single time point and only very few genes were differentially expressed at more than one time point.
Discussion
Analysis of gene expression data
Increased LVM/TL ratios and differentially expressed hypertrophy markers in left ventricular tissue of TAC mice confirmed cardiac hypertrophy due to the aortic banding procedure. After exclusion of all poor, negative, and empty spots (flagged by ImaGene), about 7500 probes showed a detectable expression. This is more or less the expected percentage of genes expressed in the heart [16, 17] . The expression values of the genes were judged by strict criteria (see supplementary data). At least two values per group (TAC and sham) per time point should be available. Using linear regression analysis, it was possible to detect small changes at a statistically reliable level, even using only Cy3 labeling. Not all of these small changes will be biologically relevant, but if more genes involved in the same process show a similar behavior, this provides additional evidence for a significant role for that process [18] . Several differentially expressed genes that lack additional information, such as the "Riken cDNA clones" or "expressed sequences," were discarded from further analysis, but will be studied in the future. The microarray results were validated in a number of ways, such as consistent expression of different transcripts for the same gene and real-time PCR confirmation, demonstrating the reliability of the microarray data. Comparable results of real-time PCR validation have been reported by others [19, 20] .
Early and transient alterations in expression of genes encoding metabolic and cytoskeletal proteins
The most striking differences in gene expression were observed for energy metabolism and cytoskeleton. Genes encoding proteins involved in glycolysis, FA metabolism, and mitochondrial processes such as the TCA cycle and respiratory chain were in general downregulated at 48 h. In contrast, genes involved in mitochondrial protein import and mitochondrial protein synthesis were found to be upregulated. This most likely reflects an initial downregulation of genes involved in energy conversion pathways in favor of the expression of genes for anabolic processes such as mitochondriogenesis. The simultaneous increase in a number of mitochondrial ribosomal genes and Mtif2 (mitochondrial translational initiation factor 2) at 48 h supports this contention and may indicate that the first response to TAC also occurs at the level of translation. Moreover, changes in gene expression at 1 week could be an indication of increased glycolytic activity of the heart at this time point. In addition, the mainly increased expression of cytoskeletal genes indicates a switch to renewed growth. This was most evident at 1 week, which is in line with the increased left ventricular mass 1 week after TAC. Adjustment of structure and size of myofibrils is an early response to cope with increased workload. This emphasizes the physiological changes during early cardiac hypertrophy, since the increase in cardiomyocyte size requires an adaptation in cytoarchitecture.
Recently, Wagner and co-workers published the results of a microarray study performed in hearts of TAC mice at one single time point, i.e., 20 days after aortic banding [21] . They consider the processes identified in their study as maladaptive, among which a downregulation of several metabolic genes, since cardiac hypertrophy can lead to heart failure. In this respect it is worth noting that some studies have reported a shift in substrate preference from FA to glucose in mice that could precipitate the development of heart failure [22] . It has been proposed that if the reduction of FA oxidation is not fully compensated for by the increased glucose oxidation, the overall rate of ATP regeneration will decline, eventually leading to energy starvation and decrease in cardiac performance [8] . However, other investigators have not identified this shift or even showed an increase in the use of FA in the hypertrophied heart [8, 10] . Moreover, overexpression of Glut1 (glucose transporter 1) was reported to prevent the development of heart failure due to chronic pressure overload by increasing myocardial glucose uptake and thus represents a beneficial adaptation [23] . Glut1 was not present in our cDNA collection, but upregulation of Stx4a (syntaxin 4A, required for Glut8 (glucose transporter 8) translocation) in the mice at 1 week after TAC supports these findings. The results from Wagner and colleagues regarding changes in expression of genes encoding proteins involved in energy metabolism and cytoskeletal remodeling are similar to ours. However, the strength of our approach is the investigation of more than one time point, enabling us to demonstrate that during the later hypertrophic phases (2, 3, and 8 weeks), gene expression in these processes returns to basal levels again.
In summary, the observed changes in expression of genes involved in energy metabolism most likely reflect a transition to temporary growth of the myocardium as an adaptation to the increase in pressure overload and do not necessarily represent a maladaptive process. The increased expression of structural and sarcomeric genes may provide important cytoskeletal support for the hearts of the aortabanded Swiss mice, such that hypertrophy does not progress to failure, not even in the long term in this particular experimental model.
Other significant processes during the early phase of cardiac hypertrophy
Reexpression of fetal genes was identified at 48 h: not only Nppa, Myh7, Pln, and Nrap (nebulin-related anchoring protein) were differentially expressed, but also several other embryonic genes. Melk (maternal embryonic leucine zipper kinase) is a member of the Snf1/AMPK serine/threonine kinase family and has so far been implicated only in mammalian embryogenesis, with the highest expression during maturation of oocytes and preimplantation development [24] . In addition, Hoxb3 (homeobox 3), Mfng (manic fringe homolog, Drosophila), Tdgf1 (teratocarcinoma-derived growth factor 1), and Cul1 (cullin 1) were differentially expressed. These findings reflect the activation of fetal gene expression in cardiac hypertrophy, which may be cause or consequence of the renewed growth [4, 5] .
Several genes associated with β-amyloid metabolism showed a downregulation during the initial hypertrophic phase, such as App (amyloid β precursor protein) and Aplp2 (amyloid β (A4) precursor-like protein 2). β-Amyloid is a small piece of the larger protein App, of which the normal function has not yet been determined. Another gene present in the cluster of β-amyloid-related genes was Itmb2, which has been associated with familial British dementia [25] . It has been reported before that coronary artery disease and hypertension may be a forerunner to Alzheimer disease [26] , and recently another link between hypertrophy and Alzheimer disease has been proposed in hypertrophic mice after treatment with Ang II [27] . The precise roles of these genes in the hypertrophic process remain, however, to be elucidated. Furthermore, processes such as transcription; cell growth; development; signaling; nucleobase, nucleoside, nucleotide, and nucleic acid metabolism (e.g., DNA and RNA metabolism); translation; protein biosynthesis; and protein degradation contained a significant number of differentially expressed genes at distinct time intervals after TAC. The number of genes that were differentially expressed at more than one time point was very low, which combined with the high number of genes that was differentially expressed at only one time point, also reported by Zhao et al. [16] , suggests that processes either are stage specific or, more likely, may not be primarily related to the hypertrophy process in the compensated state.
Changes occurring at the later (compensated) hypertrophic phase
Although the changes in gene expression were much more pronounced during the acute phase (48 h) and at 1 week after TAC, we also identified several genes not previously reported as hypertrophy-related genes during the later hypertrophic phase, such as Cetn2 (centrin 2) and Plxnb1 (plexin b), respectively up-and downregulated at 8 weeks. Activation of signaling pathways such as G-protein signaling, MAPK signaling, Wnt signaling, and TGFβ signaling was identified at the different time points, although genes related to TGFβ signaling were slightly upregulated only at 8 weeks after banding. Differences in gene expression were only modest at these later time points and the differentially expressed genes could less easily be grouped into certain processes. A direct relation to the hypertrophic process remains therefore questionable.
Conclusions
Although alterations in gene expression in response to changes in the hemodynamic environment of the heart have been reported previously [21, 28, 29] , these studies were restricted to only a few genes or to one particular time point. In our study, compensated hypertrophy is characterized by an initial, but temporary, restriction in the expression of genes encoding myocardial energy metabolism in the early prehypertrophic phase associated with an investment in the expression of genes involved in the construction of the cytoskeletal and sarcomeric apparatus to deal with the increased workload. The full establishment of cardiac hypertrophy 1 week after aortic constriction is associated with an upregulation of genes involved in glycolytic activity and activation of fetal gene expression. The fact that the hearts of TAC mice do not show signs of overt failure, as assessed 28 weeks after aortic banding, strongly suggests that the observed (transient) alterations in gene expression are most likely beneficial rather than detrimental in nature. Additional studies should be performed to evaluate the functional consequences of these changes.
Further cross-comparisons of different mouse models (with or without transition to heart failure) will allow a more detailed insight into these underlying processes and pathways depending on the genetic or etiologic origins of hypertrophy and heart failure. TAC has also been reported to lead to decompensated hypertrophy or induction of heart failure, likely influenced by animal species or strain differences between the mice [30, 31] . Therefore, comparisons of different mouse strains may also reveal modifier genes that could Fig. 3 . Schematic overview of the most important processes identified at the different time intervals after TAC. FA, TCA, and OXPHOS refer to fatty acid metabolism, citric acid cycle, and oxidative phosphorylation, respectively. TGFβ refers to tissue growth factor β. increase our knowledge with respect to the variability in the phenotypic expression of hypertrophy and heart failure in patients. Whether the processes identified by these studies will be useful for prognosis in the clinical setting remains to be determined. Time series experiments are an important aspect in these comparisons, as the eventual outcome will determine the conclusions regarding the adaptive or maladaptive nature of certain genes and the processes they are involved in.
Materials and methods
TAC mice
A total of 60 male inbred Swiss mice (10 weeks of age, body wt 27-35 g) were randomly allocated to the TAC and sham-operation groups. Mice were anesthetized with a combination of ketamine (100 mg/kg intramuscularly) and xylazine (5 mg/kg subcutaneously). TAC was performed as described by Rockman et al. [15] . Sham-operated mice underwent an identical surgical procedure without the actual constriction of the aorta. All procedures were performed in accordance with the recommendations of the Guide for the Care and Use of Laboratory Animals published by the U.S. National Institutes of Health (NIH Publication No. 85-23, revised 1996) and approved by the Committee for Animal Research of Maastricht University. Mice were sacrificed at 48 h, 1 week, and 2, 3, and 8 weeks after surgery. Hearts were harvested, weighed, and frozen in liquid nitrogen. Hypertrophy was assessed by determining the ratio LVM/TL. In a subset of animals (TAC, n = 5; sham, n = 5), cardiac function was assessed with echocardiography at 28 weeks following the intervention.
Microarray preparation
In general, the microarray experiments were performed according to the MIAME (Minimum Information about a Microarray Experiment) recommendations [32] . The cDNA inserts from the NIA (National Institute on Aging) Mouse 15K cDNA collection, derived from embryonic and fetal cells and tissues [33] , were PCR amplified directly from the glycerol stocks. The insert sizes of eight clones per 96-well plate were verified as a quality check. After purification, PCR products were resuspended at a concentration of 200 ng/μl in 50% DMSO and spotted onto UltraGAPS coated slides (Corning) using the Microgrid II arrayer (Biorobotics). This arrayer is mounted with a 16-pin head and slides were printed in three separate runs. Each slide consisted of three metagrids, subdivided in 16 subgrids, corresponding to the area printed by each pin. Each subgrid has 20 rows and columns, yielding 400 spots per subgrid, 6400 per metagrid.
The total of 19,200 spots consisted of 15,120 cDNA clones and 4080 controls. Five positive controls (i.e., housekeeping genes) were spotted six times by each pin in every metagrid. Three negative controls (i.e., bacterial genes) and DMSO were spotted four times by every pin in each of the three metagrids. Finally, 15 spots were left empty in each of the 16 subgrids of the three metagrids. Each of these products was spotted in positions chosen uniformly across the subgrid and therefore the slide.
RNA extraction, labeling, and hybridization
Total left ventricular RNA was extracted using the TRIzol reagent (Invitrogen) and purified with the RNeasy Clean-Up kit (Qiagen). RNA quality was determined with the Bioanalyser (Agilent). As the Cy5 dyes have been reported to be unstable at high amounts of atmospheric ozone [34] , we decided to use only Cy3 labeling and compare the samples hybridized on different slides. Reproducibility was checked by performing replicate hybridizations for five samples. Aminoallyl labeling and RNA hybridization were performed according to the protocol by Hegde et al. [35] and slightly adjusted for use in our own laboratory. Briefly, 10 μg of total RNA from each sample was reverse transcribed into cDNA using random primers in the presence of aminoallyl dUTP. Following purification, products were coupled to Cy3 NHS-ester (Amersham). Labeled cDNAs were purified and labeling efficiency was determined. Slides were prehybridized in 1% bovine serum albumin, 50% formamide, 5× SSC, and 0.1% SDS for 45 min at 42°C and then washed and dried. The labeled cDNA was resuspended in 60 μl hybridization mix, containing 50% formamide, 5× SSC, 0.1% SDS, and 8 μg mouse CotI DNA and hybridized to the arrays at 42°C for 16 h. Slides were washed 4 min at 42°C in 1× SSC/0.2% SDS, 4 min at room temperature in 0.1× SSC/0.2% SDS, and finally 4 min at room temperature in 0.1× SSC. Slides were dried by centrifugation for 5 min at 500 rpm and scanned with a dual-laser scanner (Affymetrix/GMS 418).
Microarray analysis
Images were quantified with ImaGene software (BioDiscovery). Any probe that was flagged as empty, negative, or poor or had fewer than two observations left per TAC or sham group was excluded from further analysis. A more detailed description of this analysis is shown in the supplementary data. Briefly, the remaining genes were analyzed using a Gaussian linear regression including the labeling efficiency and, when necessary, the repeats. The inference criterion used for comparing the models is their ability to predict the observed data, i.e., models are compared directly through their minimized minus log-likelihood. When the numbers of parameters in models differ, they are penalized by adding the number of estimated parameters, a form of the Akaike information criterion (AIC) [36] . For each gene, the treatment group was then added to the model. The gene under consideration was found to be differentially expressed if the AIC decreased compared to the model not containing the treatment. 
We focused on differentially expressed genes with a known LL ID (in the meantime replaced by GeneID). The genes analyzed and fold changes were loaded into GenMapp [11] and MAPPFinder [12] to evaluate the transcripts in relation to known biological processes, molecular function, and cellular component based on Gene Ontology terms and to obtain a ranked list (using p < 0.05) of pathways with differentially expressed genes. To reveal unknown relations between genes, we used the TXTGate Web service, which clusters genes using literature-based information [13] . In addition, the expression profile of the differentially expressed genes in time was investigated using Adaptive Quality-Based Clustering [14] . This interface is intended to find groups of genes that have similar expression profiles.
Real-time PCR
Real-time quantitative PCR (TaqMan, Applied Biosystems) was performed using the SYBR Green PCR Core Reagents (Applied Biosystems). Reverse transcription into cDNA was performed in a 40-μl volume with 1.25 μg total RNA as a template. After denaturing at 65°C for 10 min, the RNA, the firststrand buffer, 1.25 mM dNTPs, 200 U Superscript II (Invitrogen), RNAsin, and a mixture of 0.75 μg oligo(dT) primer and 0.75 μg random primers (Invitrogen) were incubated for 1 h at 42°C followed by 5 min at 95°C. Primers were created using Primer Express software (Applied Biosystems) based on GenBank sequences ( Table 3 ). The cDNA was amplified in duplo in 20 μl SYBR Green PCR buffer, with 4 mM MgCl 2 , 1.25 mM dNTP mix, 0.25 U AmperaseUNG, 0.625 U AmpliTaq Gold DNA polymerase, and 1.25 pmol of the forward or reverse primer. PCR conditions were, first, 50°C for 2 min, 95°C for 10 min, followed by 40 cycles of 95°C for 15 s/60°C for 1 min. Next, samples were heated to 95°C for 15 s, cooled at 60°C for 1 min, and then heated to 95°C in 20 min, followed by cooling to 4°C to create a dissociation curve to check for nonspecific amplification. In addition, serial dilutions from the cDNA were analyzed for each target gene to assess PCR efficiency. Transcription values were related to the housekeeping gene Ppia (peptidylprolyl isomerase A or cyclophilin). The results were analyzed using a Gaussian linear regression, similar to the microarray analysis, with the adjustment of adding Ppia as a housekeeping gene. The AIC was also used to assess whether there was a difference between the controls and TAC mice (group effect). Hence, the gene under consideration was found to be differentially expressed if the AIC decreased compared to the model not containing the group difference.
